Elinzanetant RC00889
929046-33-3
Pharmaceutical Grade
99%
中国
Royalchem
25kg/drum
2025-12-31
Pharmaceutical intermediates
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
N-{6-[(7S,9aS)-7-(hydroxymethyl)-octahydropyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl}-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide
Other Name:N-{6-[(7S,9aS)-7-(hydroxymethyl)-octahydropyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl}-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide;Benzeneacetamide, N-[4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-hexahydro-7-(hydroxymethyl)pyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl]-N,α,α-trimethyl-3,5-bis(trifluoromethyl)-;Elinzanetant
CAS No.:929046-33-3
Molecular Formula:C33H35F7N4O3
InChIKeys:DWRIJNIPBUFCQS-DQEYMECFSA-N
Molecular Weight:668.66
Exact Mass:668.25973813
EC Number:629-865-8
UNII:NZW2BOW35N
Categories:
Characteristics-
Density:
1.40±0.1 g/cm3
Boiling Point:672.1±55.0 °C(Predicted)
PKA:14.57±0.10
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceutical intermediates
-
Location:
Room 336, Building 7, No. 177 Xingqiao North Road, Xingqiao Street, Linping District, Hangzhou
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
14
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2025
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product